2D in-vivo L-COSY spectroscopy identifies neurometabolite alterations in treated multiple sclerosis

- Quadrelli, Scott, Ribbons, Karen, Arm, Jameen, Al-iedani, Oun, Lechner-Scott, Jeannette, Lea, Rodney, Ramadan, Saadallah

A comparative analysis of patient-reported expanded disability status scale tools

- Collins, Christian D. E., Ivry, Ben, Bowen, James D., Cheng, Eric M., Dobson, Ruth, Goodin, Douglas S., Lechner-Scott, Jeannette, Kappos, Ludwig, Galea, Ian

A comparison between the pathophysiology of multiple sclerosis and normal pressure hydrocephalus: is pulse wave encephalopathy a component of MS?

- Bateman, Grant A., Lechner-Scott, Jeannette, Lea, Rodney A.

A new era in the treatment of multiple sclerosis

- Broadley, Simon A., Barnett, Michael H., Marriott, Mark, Mason, Deborah F., Parratt, John, Reddel, Stephen W., Shaw, Cameron P., Slee, Mark, Spies, Judith M., Taylor, Bruce V., Carroll, William M., Kilpatrick, Trevor J., Boggild, Mike, King, John, McCombe, Pamela A., Pollard, John D., Willoughby, Ernest, Brew, Bruce J., Butzkueven, Helmut, Heard, Robert, Hodgkinson, Suzanne, Kermode, Allan G., Lechner-Scott, Jeannette, Macdonell, Richard A. L.

A rare P2X7 variant Arg307Gln with absent pore formation function protects against neuroinflammation in multiple sclerosis

- Gu, Ben J., Field, Judith, Butzkueven, Helmut, Gresle, Melissa, Laws, Simon M., Petrou, Steven, Hoffjan, Sabine, Akkad, Denis A., Graham, Colin A., Hawkins, Stanley, Glaser, Anna, Bedri, Sahl Khalid, Dutertre, Sébastien, Hillert, Jan, Matute, Carlos, Antiguedad, Alfredo, Wiley, James S., Ou, Amber, Kilpatrick, Trevor J., Lechner-Scott, Jeannette, Scott, Rodney, Lea, Rodney, Taylor, Bruce V., Stankovich, Jim

A transcription factor map as revealed by a genome-wide gene expression analysis of whole-blood mRNA transcriptome in multiple sclerosis

- Riveros, Carlos, Mellor, Drew, Vucic, Stephen, Stewart, Graeme J., Williams, David W., Scott, Rodney J., Lechner-Scott, Jeannette, Booth, David R., Moscato, Pablo, ANZgene Multiple Sclerosis Genetics Consortium, Gandhi, Kaushal S., McKay, Fiona C., Cox, Mathew B., Berretta, Regina, Vaezpour, S. Yahya, Inostroza-Ponta, Mario, Broadley, Simon A., Heard, Robert N.

Altered expression of the plasminogen activation pathway in peripheral blood mononuclear cells in multiple sclerosis: possible pathomechanism of matrix metalloproteinase activation

- Cox, Mathew B., Bowden, Nikola A., Scott, Rodney J., Lechner-Scott, Jeannette

Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis

- Beecham, Ashley H., Patsopoulos, Nikolaos A., Oturai, Annette, Saarela, Janna, Fontaine, Bertrand, Hemmer, Bernhard, Martin, Claes, Zipp, Frauke, D'Alfonso, Sandra, Martinelli-Boneschi, Filippo, Taylor, Bruce, Harbo, Hanne F., Xifara, Dionysia K., Lechner-Scott, Jeannette, Davis, Mary F., Kemppinen, Anu, Cotsapas, Chris, Shah, Tejas S., Spencer, Chris, Booth, David, Goris, An

Anxiety levels are independently associated with cognitive performance in an Australian multiple sclerosis patient cohort

- Ribbons, Karen, Lea, Rodney, Schofield, Peter W., Lechner-Scott, Jeannette

Automatic prediction of the conversion of clinically isolated syndrome to multiple sclerosis using deep learning

- Afzal, H. M. Rehan, Luo, Suhuai, Ramadan, Saadallah, Lechner-Scott, Jeannette, Li, Jiaming

Cladribine versus fingolimod, natalizumab and interferon β for multiple sclerosis

- Kalincik, Tomas, Jokubaitis, Vilja, Duquette, Pierre, Grammond, Pierre, Solaro, Claudio, Grand'Maison, Francois, Hupperts, Raymond, Prevost, Julie, Sola, Patrizia, Ferraro, Diana, Terzi, Murat, Butler, Ernest, Spelman, Tim, Slee, Mark, Kermode, Allan, Fabis-Pedrini, Marzena, McCombe, Pamela, Barnett, Michael, Shaw, Cameron, Hodgkinson, Suzanne, Butzkueven, Helmut, MSBase Study Group,, Horakova, Dana, Havrdova, Eva, Trojano, Maria, Lechner-Scott, Jeannette, Lugaresi, Alessandra, Prat, Alexandre, Girard, Marc

Clinical and therapeutic predictors of disease outcomes in AQP4-IgG + neuromyelitis optica spectrum disorder

- Kunchok, Amy, Malpas, Charles, Ozakbas, Serkan, Olascoaga, Javier, Simo, Magdolna, Granella, Franco, Patti, Francesco, McCombe, Pamela, Csepany, Tundle, Singhal, Bhim, Bergamaschi, Roberto, Fragoso, Yara, Nytrova, Petra, Al-Harbi, Talal, Turkoglu, Recai, Lechner-Scott, Jeannette, Laureys, Guy, Oreja-Guevara, Celia, Pucci, Eugenio, Sola, Patrizia, Ferraro, Diana, Altintas, Ayse, Soysala, Aysun, Havrdova, Eva Kubala, Vucic, Steve, Grand'Maison, Francois, Izquierdo, Guillermo, Eichau, Sara, Lugaresi, Alessandra, Onofrj, Marco, Trojano, Maria, Marriott, Mark, Butzkueven, Helmut, Kister, Ilya, Alroughani, Raed, Kalincik, Tomas, Terzi, Murat, Yamout, Bassem, Hor, Jyh Yung, Karabudak, Rana, Boz, Cavit

Common and low frequency variants in MERTK are independently associated with multiple sclerosis susceptibility with discordant association dependent upon HLA-DRB1*15:01 status

- Binder, Michele D., Fox, Andrew D., Laverick, Louise, Foo, Grace, Fabis-Pedrini, Marzena J., Spelman, Timothy, Jordan, Margaret A., Baxter, Alan G., Foote, Simon, Merlo, Daniel, Lechner-Scott, Jeannette, Johnson, Laura J., Moscato, Pablo, Scott, Rodney, Giuffrida, Sarah E., Calvert, Rainer, Akkermann, Rainer, Ma, Gerry Z. M., Perera, Ashwyn A., Gresle, Melissa M.

Common genetic variants in the plasminogen activation pathway are not associated with multiple sclerosis

- Cox, Mathew B., Bowden, Nikola A., Scott, Rodney J., Lechner-Scott, Jeannette

Comparative effectiveness of glatiramer acetate and interferon beta formulations in relapsing-remitting multiple sclerosis

- Kalincik, Tomas, Jokubaitis, Vilija, Grand'Maison, Francois, Pucci, Eugenio, Van Pesch, Vincent, Boz, Cavit, Iuliano, Gerardo, Fernandez-Bolanos, Ricardo, Flechter, Shlomo, Spitaleri, Daniele, Cristiano, Edgardo, Verheul, Ferek, Izquierdo, Guillermo, Lechner-Scott, Jeannette, Amato, Maria Pia, Cabrera-Gomez, Jose Antonio, Saladino, Maria Laura, Slee, Mark, Moore, Fraser, Gray, Orla, Paine, Mark, Barnett, Michael, Havrdova, Eva, Duquette, Pierre, Horakova, Dana, Spelman, Timothy, Trojano, Maria, Butzkueven, Helmut, Girard, Marc, Grammond, Pierre, Lugaresi, Alessandra, Oreja-Guevara, Celia, Bergamaschi, Roberto, Hupperts, Raymond

Comparative efficacy of first-line natalizumab vs IFN-ß or glatiramer acetate in relapsing MS

- Spelman, Tim, Kalincik, Tomas, Havrdová, Eva, Horáková, Dana, Grammond, Pierre, Duquette, Pierre, Prat, Alexandre, Iuliano, Gerardo, Terzi, Murat, Izquierdo, Guillermo, Hupperts, Raymond M.M., Jokubaitis, Vilija, Lechner-Scott, Jeannette, Zhang, Annie, Pellegrini, Fabio, Wiendl, Heinz, Belachew, Shibeshih, Hyde, Robert, Verheul, Freek, Lugaresi, Alessandra

Comparative efficacy of switching to natalizumab in active multiple sclerosis

- Spelman, Timothy, Kalincik, Tomas, Grand-Maison, Francois, Izquierdo, Guillermo, Grammond, Pierre, Duquette, Pierre, Lugaresi, Alessandra, Lechner-Scott, Jeannette, Oreja-Guevara, Celia, Hupperts, Raymond, Petersen, Thor, Barnett, Michael, Zhang, Annie, Trojano, Maria, Butzkueven, Helmut, Pellegrini, Fabio, Wiendl, Heinz, Kappos, Ludwig, Tsvetkova, Larisa, Belachew, Shibeshih, Hyde, Robert, Verheul, Freek

Comparing genotyping algorithms for Illumina's Infinium whole-genome SNP BeadChips

- Ritchie, Matthew E., Ruijie, Liu, Kilpatrick, Trevor J., Lechner-Scott, Jeannette, Moscato, Pablo, Perreau, Victoria M., Rubio, Justin P., Scott, Rodney J., Stankovich, Jim, Stewart, Graeme J., Taylor, Bruce V., Wiley, James, Carvalho, Benilton S., Booth, David R., Clarke, Glynnis, Cox, Mathew B., Csurhes, Peter A., Danoy, Patrick, Dickinson, Joanne L., Drysdale, Karen, Field, Judith, Greer, Judith M., Griffiths, Lyn R., Irizarry, Rafael A., Guru, Preethi, Hadler, Johanna, Hoban, Ella, McMorran, Brendan J., Jensen, Cathy J., Johnson, Laura J., McCallum, Ruth, Merriman, Marilyn, Merriman, Tony, Polanowski, Andrea, Bahlo, Melanie, Pryce, Karena, Tajouri, Lotfi, Whittock, Lucy, Wilkins, Ella J., Browning, Brian L., Browning, Sharon R., Perera, Devindri, Butzkueven, Helmut, Carroll, William M., Chapman, Caron, Kermode, Allan G., Marriott, Mark, Mason, Deborah, Heard, Robert N., Pender, Michael P., Slee, Mark, Tubridy, Niall, Willoughby, Ernest, Broadley, Simon A., Brown, Matthew A., Foote, Simon J.

Comparison of switch to fingolimod or interferon beta/glatiramer acetate in active multiple sclerosis

- He, Anna, Spelman, Tim, Jokubaitis, Vilija, Havrdova, Eva, Horakova, Dana, Trojano, Maria, Lugaresi, Alessandra, Izquierdo, Guillermo, Grammond, Pierre, Duquette, Pierre, Girard, Marc, Pucci, Eugenio, Iuliano, Gerardo, Alroughani, Raed, Oreja-Guevara, Cekia, Fernandez-Bolaños, Ricardo, Grand'Maison, Francois, Sola, Patrizia, Spitaleri, Daniele, Granella, Franco, Lechner-Scott, Jeannette

Comparison of the sagittal sinus cross-sectional area between patients with multiple sclerosis, hydrocephalus, intracranial hypertension and spontaneous intracranial hypotension: a surrogate marker of venous transmural pressure?

- Bateman, Grant A., Lechner-Scott, Jeannette, Copping, Ross, Moeskops, Christopher, Yap, Swee Leong